Divis Laboratories Ltd Sees Surge in Put Options with 6,125 Contracts Traded at Rs 6000 Strike

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today, particularly in the options market. The company’s underlying stock, DIVISLAB, is currently trading at Rs 6001.5, with a notable focus on put options expiring on August 28, 2025.
Today, 6,125 put contracts were traded at a turnover of Rs 779.16 lakhs, indicating significant activity in this segment. The strike price for these puts is set at Rs 6000, with an open interest of 1,061 contracts, reflecting ongoing interest among traders.

In terms of performance, Divis Laboratories has underperformed its sector by 1.53%, with the stock experiencing a consecutive decline over the past three days, resulting in a total drop of 7.67%. The stock reached an intraday low of Rs 5960.5, down 2.82% from the previous close. Additionally, it is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend.

Despite these challenges, there has been a rise in investor participation, with delivery volume increasing by 27.39% compared to the 5-day average. The liquidity remains adequate for trades, with a size of Rs 7.34 crore based on 2% of the 5-day average traded value.

In summary, Divis Laboratories Ltd is witnessing significant activity in its put options, amidst a backdrop of declining stock performance and increasing investor engagement.